Understanding Optimal Blood Pressure Meds with ACEIs, ARBs, CCBs
Overview
As a clinical pharmacist, selecting initial BP meds for uncomplicated hypertension (HTN) often involves ACE inhibitors (ACEI), angiotensin receptor blockers (ARB), calcium channel blockers (CCB), or thiazide diuretics. Here are some key considerations...
Initial Blood Pressure Medications
ACE Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs)
ARBs reduce cardiovascular (CV) risk on par with ACEIs but cause fewer adverse effects like cough or angioedema. Both ARBs and ACEIs are available as low-cost generics.
- Prefer long-acting ARBs such as telmisartan or olmesartan to reduce BP swings and improve adherence.
- Losartan, the shortest-acting ARB, often requires BID dosing.
- Avoid switching an optimized and well-tolerated ACEI regimen to an ARB.
Calcium Channel Blockers (CCBs)
Amlodipine is a reliable CCB, offering long action, less tachycardia, and proven CV outcomes in HTN. Peripheral edema is common with CCBs but often not due to sodium or water retention. Reduce the CCB dose or add an ACEI/ARB to counteract edema.
Thiazide Diuretics
No clear winner exists among thiazide diuretics. Chlorthalidone and indapamide show CV benefits, especially in the elderly, possibly due to longer action and better BP control. Recent data suggest chlorthalidone causes more hypokalemia than hydrochlorothiazide (HCTZ). Any thiazide can be effective if it controls BP, especially in combination with other medications. Consider HCTZ for many patients due to its availability in many combinations and lower cost.
Conclusion
In summary, selecting the right blood pressure medication for uncomplicated hypertension involves evaluating the specific benefits and drawbacks of ACEIs, ARBs, CCBs, and thiazides to optimize patient outcomes.
Take-home points
- ARBs reduce CV risk like ACEIs but cause fewer side effects.
- Both ARBs and ACEIs are low-cost generics.
- Prefer long-acting ARBs like telmisartan or olmesartan for stable blood pressure.
- Amlodipine, a reliable CCB, has long action and fewer side effects.
- Manage CCB-induced peripheral edema by adjusting dosage or adding an ACEI/ARB.
- Chlorthalidone and indapamide may control BP better in elderly but increase hypokalemia risk.
- Consider hydrochlorothiazide for its cost-effective combinations.
References
- Chen R, Suchard MA, Krumholz HM, et al. Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study. Hypertension. 2021;78(3):591-603
- Whelton PK, Carey RM. The 2017 Clinical Practice Guideline for High Blood Pressure. JAMA. 2017;318(21):2073-2074
- Ishani A, Cushman WC, Leatherman SM, et al. Chlorthalidone vs. Hydrochlorothiazide for Hypertension-Cardiovascular Events. N Engl J Med. 2022;387(26):2401-2410
Keywords: Blood pressure medications, ACE inhibitors, ARBs, Calcium channel blockers, Thiazide diuretics, Hypertension treatment
Join the conversation